NYXH
Nyxoah S.A.
NASDAQ · Healthcare · Medical - Instruments & Supplies · BE
$1.62
−7.95%Aug 5, 2026, 20:05 UTC
Nyxoah reported financial and operating results for the second quarter and first half of 2026, with U.S. net revenue of €5.2 million and global net revenue of €7.7 million for Q2 2026.
Jul 10, 2026, 23:02 UTC
Nyxoah announced the U.S. launch of its Genio hypoglossal nerve stimulation system.
Source:Jun 15, 2026, 20:05 UTC
Nyxoah SA's Genio hypoglossal nerve stimulation therapy won the Prix Galien UK 2026 Award for Best Medical Technology at a ceremony in London.
Jun 10, 2026, 20:30 UTC
Nyxoah SA anticipates receipt of the $15 million second tranche of its European Investment Bank loan.
Jun 8, 2026, 20:44 UTC
TPG RE Finance Trust, Inc. declared a cash dividend of $0.3906 per share on its Series C Cumulative Redeemable Preferred Stock for the second quarter of 2026.
Jun 8, 2026, 20:15 UTC
Global Ship Lease declared a quarterly cash dividend of $0.546875 per depositary share on its 8.75% Series B Cumulative Redeemable Perpetual Preferred Shares.
Jun 8, 2026, 20:05 UTC
Agree Realty Corporation declared a monthly cash dividend of $0.267 per common share, payable July 15, 2026.
Source:Jun 8, 2026, 20:05 UTC
Mission Produce's Board of Directors authorized a new share repurchase program for up to $100 million of shares over the next 3 years.
Source:Jun 5, 2026, 15:25 UTC
Nyxoah SA priced an underwritten public offering of 55,232,558 ordinary shares at $1.72 per share to raise approximately $95 million.
Jun 5, 2026, 12:58 UTC
Douglas Dynamics, Inc. declared a quarterly cash dividend of $0.295 per share for the second quarter of 2026.
Source:Jun 4, 2026, 20:01 UTC
Nyxoah SA announced the commencement of a leadership transition process to replace CEO Olivier Taelman with a U.S.-based CEO.
Source: